FWI
GILD icon

Facet Wealth Inc’s Gilead Sciences GILD Stock Holding History

Facet Wealth Inc’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$397K Buy
2,850
+591
+26% +$82.8K 0.01% 204
2025
Q4 		$316K Buy
+2,259
New +$275K 0.01% 216

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Facet Wealth Inc's GILD Position: Q1 2026 in Review

Facet Wealth Inc increased its Gilead Sciences (GILD) stake by 26% in Q1 2026, buying an estimated $82.8K and bringing the position to 2,850 shares worth $397K. The position accounts for 0.01% of the portfolio, ranked #204.

Facet Wealth Inc first reported a position in GILD in Q4 2025 and has held it in 2 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Facet Wealth Inc held 2,850 shares of Gilead Sciences worth $397K as of Q1 2026.
  • Facet Wealth Inc bought 591 Gilead Sciences shares in Q1 2026, an estimated $82.8K.
  • Gilead Sciences made up 0.01% of Facet Wealth Inc's portfolio in Q1 2026, its #204 holding.
  • Facet Wealth Inc first reported a position in Gilead Sciences in Q4 2025 and has held it in 2 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Facet Wealth Inc's 13F filing for Q1 2026, filed 7 May 2026.